Gary Kobinger
Gary P. Kobinger is a Canadian immunologist and virologist who is currently the director at the Galveston National Laboratory at the University of Texas. He has held previous professorships at Université Laval, the University of Manitoba, and the University of Pennsylvania. Additionally, he was the chief of the Special Pathogens Unit at the National Microbiology Laboratory (NML) of the Public Health Agency of Canada (PHAC) in Winnipeg, Manitoba, for eight years. Kobinger is known for his critical role in the development of both an effective Ebola vaccine and treatment. His work focuses on the development and evaluation of new vaccine platforms and immunological treatments against emerging and re-emerging viruses that are dangerous to human health. Provided by Wikipedia-
1by Xiangguo Qiu, Lisa Fernando, P Leno Melito, Jonathan Audet, Heinz Feldmann, Gary Kobinger, Judie B Alimonti, Steven M JonesGet access
Published in PLoS Neglected Tropical Diseases (2012)
Get access
Article in Journal/Newspaper -
2by Kamalini Lokuge, Grazia Caleo, Jane Greig, Jennifer Duncombe, Nicholas McWilliam, James Squire, Manjo Lamin, Emily Veltus, Anja Wolz, Gary Kobinger, Marc-Antoine de la Vega, Osman Gbabai, Sao Nabieu, Mohammed Lamin, Ronald Kremer, Kostas Danis, Emily Banks, Kathryn GlassGet access
Published in PLOS Neglected Tropical Diseases (2016)
Get access
Article in Journal/Newspaper